By API User
Geologists have for the first time determined how coastal mountains in eastern Asia formed, resulting in significant changes to the continent’s climate more than 100 million years ago. Until now, there were questions around the Asian climate during this time, commonly referred to as the Cretaceous period. New research published in Science Advances shows the sudden … Continued
By API User
Monash experts are available to discuss Victoria’s first pill testing trial, to be available to an estimated 35,000 festival goers at Beyond The Valley, a four-day music event in the Golden Plains Shire from 28 December until 1 January 2025. Associate Professor Jennifer Schumann, Department of Forensic Medicine, Monash University Contact: +61 3 9903 … Continued
By API User
Pneumococcal outbreak worst in 20 years Rollout of new generation vaccines must begin now Rates of pneumococcal disease – a life-threatening bacterial infection that can attack the lungs, brain and bloodstream – have hit a 20-year high, according to national notifiable disease data.1 The Immunisation Foundation of Australia today revealed that more than … Continued
By API User
The Royal Australian College of GPs has welcomed the Australian Government’s support for nationally consistent rules for prescribing medication for Australians living with attention deficit hyperactivity disorder (ADHD). It came in the Government’s response to the Senate Community Affairs References Committee report: Assessment and support services for people with attention deficit hyperactivity disorder (ADHD), released … Continued
By API User
South Australia’s Premier Peter Malinauskas and Minister for Health and Wellbeing Chris Picton ran alongside RACGP President Dr Michael Wright and South Australia Chair Dr Sian Goodson in the Nantu Wama parkrun in North Adelaide this morning. The Royal Australian College of GPs partnered with non-profit parkrun Australia to support GPs across the nation in tackling … Continued
By API User
Ad hoc announcement pursuant to Art. 53 LR Approximately 7% of people in the United States (U.S.) have atopic dermatitis – a common, chronic, and flaring inflammatory skin disease, characterized by persistent itch and recurrent skin lesions1-4 While currently available treatments may improve some signs and symptoms of the disease, many patients do not respond … Continued
By API User
Australian researchers have discovered a potential new lifeline for the tiniest and most vulnerable newborns. Scientists at Monash Children’s Hospital have successfully collected and reinfused umbilical cord blood cells in extremely premature babies, offering a glimmer of hope for preventing brain injuries. This pioneering Australian research, undertaken by a collaboration of Monash Health’s Monash Children’s … Continued
By API User
TOKYO & MONT-SAINT-GUIBERT, Belgium–BUSINESS WIRE– BrightPath Bio (Tokyo Stock Exchange Growth 4594, “BrightPath”), a pioneer in iPS cell-derived Natural Killer T (“NKT”) cell therapy, and Cellistic, a leader in advanced iPS cell therapy manufacturing, today announced a process development and manufacturing agreement to advance BrightPath’s novel allogeneic CAR-T cell therapy platform, utilizing iPSC-derived NKT cells … Continued
By API User
Atopic dermatitis is a common, chronic, and flaring inflammatory skin disease characterized by persistent itch and recurrent skin lesions, and affects approximately up to 40 million people in the European Union (EU)1-4 Prurigo nodularis is a serious skin disease characterized by chronic itch, skin nodules covering large body areas, and poor sleep quality, which is … Continued
By API User
TOKYO–BUSINESS WIRE– Oasis Management Company Ltd. (hereinafter referred to as “Oasis Management”), an investment management firm and a shareholder of our company, released a statement regarding Director candidates to be proposed at our 119th Ordinary General Meeting of Shareholders. Kao’s Board of Directors and management team strive to increase shareholder value from a long-term perspective … Continued
